Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1979 1
1981 1
1982 4
1983 2
1984 3
1985 3
1986 2
1988 5
1989 3
1990 5
1992 5
1993 6
1994 9
1995 11
1996 7
1997 7
1998 11
1999 12
2000 14
2001 10
2002 14
2003 20
2004 23
2005 18
2006 14
2007 15
2008 19
2009 15
2010 24
2011 15
2012 17
2013 17
2014 4
2015 7
2016 2
2017 1
2018 2
2019 2
2020 1
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group. de Boer SM, et al. Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22. Lancet Oncol. 2019. PMID: 31345626 Free PMC article. Clinical Trial.
La chirurgie ganglionnaire dans les cancers de l'utérus.
Gouy S, Uzan C, Zafrani Y, Lhommé C, Pautier P, Duvillard P, Haie-Meder C, Morice P. Gouy S, et al. Among authors: duvillard p. J Chir (Paris). 2008 Dec;145S4:12S51-5. doi: 10.1016/S0021-7697(08)74723-9. Epub 2009 Jan 23. J Chir (Paris). 2008. PMID: 22793987 French.
La chirurgie ganglionnaire dans les cancers de l'utérus.
Gouy S, Uzan C, Zafrani Y, Lhommé C, Pautier P, Duvillard P, Haie-Meder C, Morice P. Gouy S, et al. Among authors: duvillard p. J Chir (Paris). 2008 Dec;145(6S1):12S51-5. doi: 10.1016/S0021-7697(08)45010-X. J Chir (Paris). 2008. PMID: 22794074 French.
[Lymphadenectomy for uterine cancer].
Gouy S, Uzan C, Zafrani Y, Lhommé C, Pautier P, Duvillard P, Haie-Meder C, Morice P. Gouy S, et al. Among authors: duvillard p. J Chir (Paris). 2008 Dec;145 Spec no. 4:12S51-12S55. J Chir (Paris). 2008. PMID: 19194359 Review. French.
[Ovarian yolk sac tumour: general review].
Even C, Lhommé C, Duvillard P, Morice P, Balleyguier C, Pautier P, Troalen F, de La Motte Rouge T. Even C, et al. Among authors: duvillard p. Bull Cancer. 2011 Aug;98(8):963-75. doi: 10.1684/bdc.2011.1387. Bull Cancer. 2011. PMID: 21708513 Review. French.
Ovarian cancer.
Kerbrat P, Lhommé C, Fervers B, Guastalla JP, Thomas L, Tournemaine N, Basuyau JP, Cohen-Solal C, Duvillard P, Bachelot T, Ray I, Voog E, Dauplat J; French National Federation of Cancer (FNCLCC). Kerbrat P, et al. Among authors: duvillard p. Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):18-23. doi: 10.1054/bjoc.2000.1758. Br J Cancer. 2001. PMID: 11355964 Free PMC article. No abstract available.
[Sentinel lymph nodes in gynecologic cancers].
Atallah D, Rouzier R, Camatte S, Pautier P, Pomel C, Lhomme C, Haie-Meder C, Duvillard P, Castaigne D, Morice P. Atallah D, et al. Among authors: duvillard p. Bull Cancer. 2002 Jul-Aug;89(7-8):681-8. Bull Cancer. 2002. PMID: 12206981 Free article. Review. French.
Sentinel lymph node in endometrial cancer: a review.
Touboul C, Bentivegna E, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Haie-Meder C, Morice P. Touboul C, et al. Among authors: duvillard p. Curr Oncol Rep. 2013 Dec;15(6):559-65. doi: 10.1007/s11912-013-0345-1. Curr Oncol Rep. 2013. PMID: 24190831 Review.
[Endometrial surveillance of women on tamoxifen].
Lhommé C, Pautier P, Zagamé L, Taïeb S, Descamps P, Delaloge S, Morice P, Petrow P, Duvillard P. Lhommé C, et al. Among authors: duvillard p. Gynecol Obstet Fertil. 2003 Jul-Aug;31(7-8):647-56. doi: 10.1016/s1297-9589(03)00195-4. Gynecol Obstet Fertil. 2003. PMID: 14563611 Review. French.
331 results